Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 968 results
A busy London street.

Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around. Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around.

by Tim Gunn | In depth | 24 January 2023

24 January 2023

A woman receiving chemotherapy from a nurse.

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded. Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

by Tim Gunn | News | 20 January 2023

20 January 2023

  • For Researchers

Time to get stratified

As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system. As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system.

by Cancer Research UK | Analysis | 10 January 2023

10 January 2023

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

by Cancer Research UK | In depth | 15 December 2022

15 December 2022

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

A man wearing a virtual reality headset

The same techniques that make video games so popular can help us treat cancer. Owen Harris, designer of a new VR tool for studying tumours, tells us how. The same techniques that make video games so popular can help us treat cancer. Owen Harris, designer of a new VR tool for studying tumours, tells us how.

by Lilly Matson | In depth | 1 December 2022

1 December 2022

An image of a chest x-ray showing some signs of disease

Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer

by Jacob Smith | In depth | 25 November 2022

25 November 2022

Simon-Boulton-and-Kairbaan-Hodivala-Dilke

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

by Phil Prime | Interview | 22 November 2022

22 November 2022

Ian Walker

When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications. When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications.

by Ian Walker | Opinion | 16 November 2022

16 November 2022

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

by Cancer Research UK | Analysis | 14 November 2022

14 November 2022

This entry is part 7 of 16 in the series Research Integrity
T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022